Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers. // Journal of Advanced Research. – URL: https://www.sciencedirect.com/science/article/pii/S209012322600144X?dgcid=rss_sd_all
Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers. Journal of Advanced Research. https://www.sciencedirect.com/science/article/pii/S209012322600144X?dgcid=rss_sd_all
“Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers.” Journal of Advanced Research.
@article{article8520,
title = {Targeting class I HDACs suppresses oncogenic vulnerabilities and potentiates KRAS/MAPK pathway inhibitors in KRAS-mutant cancers},
journal = {Journal of Advanced Research},
url = {https://www.sciencedirect.com/science/article/pii/S209012322600144X?dgcid=rss_sd_all}
}